Chiedza Makamanzi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chiedza Makamanzi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Sarantopoulos
European University Cyprus
1 shared publication - Atshaya Lily Yokarasa
School of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus
1 shared publication - Christina Mastori-Kourmpani
School of Medicine, European University Cyprus, Nicosia, Cyprus
1 shared publication - Constantinos Tsioutis
School of Medicine, European University Cyprus, 6 Diogenes str., Nicosia 2404, Cyprus
1 shared publication - Nikolaos Spernovasilis
School of Medicine, European University Cyprus, Nicosia 2404, Cyprus
1 shared publication - Polyna Antoniou
School of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus
1 shared publication
Latest Publications
- Open Access
- 30 September 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (10) , 228
Artificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations
The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and overall healthcare delivery. This review explores the current uses, benefits, limitations, and future applications of AI in infectious diseases, highlighting its specific applications in diagnostics, clinical decision making, and personalized medicine. The transformative potential of AI in infectious diseases is emphasized, addressing gaps in rapid and accurate disease diagnosis, surveillance, outbreak detection and management, and treatment optimization. Despite these advancements, significant limitations and challenges exist, including data privacy concerns, potential biases, and ethical dilemmas. The article underscores the need for stringent regulatory frameworks and inclusive databases to ensure equitable, ethical, and effective AI utilization in the field of clinical and laboratory infectious diseases.
- 30 September 2024
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 9 (10) , 228
Open AccessArtificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations
The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and overall healthcare delivery. This review explores the current uses, benefits, limitations, and future applications of AI in infectious diseases, highlighting its specific applications in diagnostics, clinical decision making, and personalized medicine. The transformative potential of AI in infectious diseases is emphasized, addressing gaps in rapid and accurate disease diagnosis, surveillance, outbreak detection and management, and treatment optimization. Despite these advancements, significant limitations and challenges exist, including data privacy concerns, potential biases, and ethical dilemmas. The article underscores the need for stringent regulatory frameworks and inclusive databases to ensure equitable, ethical, and effective AI utilization in the field of clinical and laboratory infectious diseases.